ambroxol has been researched along with Heart Septal Defects, Ventricular in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JH | 1 |
| Xie, CJ | 1 |
| Li, L | 1 |
1 trial available for ambroxol and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Effects of ambroxol on renal function in children undergoing cardiopulmonary bypass].
Topics: Ambroxol; beta 2-Microglobulin; Blood Urea Nitrogen; Cardiopulmonary Bypass; Child; Child, Preschool | 2009 |